TABLE 2.
Stage | Description | Renal function a , b (ml/min) | GFR d (ml/min) |
---|---|---|---|
1 | Control (normal renal function)7 | ≥90 | ≥90 |
2 | Mild | 60–89 | 60 to <90 |
3 | Moderate | 30–59 | 30 to <60 |
4 | Severe | 15–29 | <30 (dialysis not required) |
5 | Kidney failure a , c ; ESRD d | <15 or dialysis patients on non‐dialysis days | <15 requiring dialysis |
Abbreviations: EMA, European Medicines Agency; ESRD, end‐stage renal disease; FDA, US Food and Drug Administration; GFR, glomerular filtration rate.
As stated in the FDA guidance.
Estimate of GFR based on an estimation equation and expressed in ml/min. To convert ml/min/1.73 m2 to ml/min multiply by the individual’s body surface area calculated using an appropriate formula and divide by 1.73.
This classification is strictly for the purposes of conducting a dedicated renal impairment study and should not be used for the purposes of classifying kidney disease.
As stated in the EMA guidance.